Breaking News

Financial Report: BASi

By Kristin Brooks | February 13, 2014

Revenues up 7% in the quarter driven by Culex sales

BASi
 
1Q Revenues: $6.2 million (+7%)
 
1Q Loss: $662,000 (earnings were $256 million 1Q12)
 
Comments: Service revenue was up 5% to $4.9 million. Product revenue increased 15% to $1.3 million, primarily due to higher sales of Culex automated sampling systems. Results include the impact of a change in warrant liability of $961,000 and a payment of $1.2 million to the company’s line of credit.
 
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks